Dr Jaffray speaks with ecancertv at ASH 2016 about the respective risks to patients fitted with central venous catheters as PICC lines, or tunnelling lines.
She describes the risk of thrombosis over time depending on device, and the considers the likelihood of infection in long-term treatment sites.
With this as the first prospective study of its kind, Dr Jaffray outlines future avenues of research, including vein specificity and expanding cohorts to infants under 6 months, and young adults.
Coverage of the press conference in which these results were announced is available here.
ecancer's filming at ASH 2016 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.